Behind the Mystery: Diagnosing Endogenous Cushing Syndrome
July 20, 2016
Strongbridge Biopharma: Driven by Passion. Focused on Results.
On today’s special series “Behind the Mystery,” we’re talking about Cushing syndrome, a rare hormonal disorder that is too often misdiagnosed where patients are simply told to lose weight! An estimated 25,000 patients in the United States and 40,000 patients in Europe are currently diagnosed with endogenous Cushing syndrome. Endogenous Cushing syndrome is believed to be underdiagnosed due to lack of disease recognition by the treating physician, which often leads to a delay in diagnosis on average of six years. Host Olga Villaverde will talk with Dr. Maria Fleseriu and patient Leslie Edwin, to raise awareness about Cushing syndrome and discuss symptoms and ways to properly diagnosis it.
Vintage after vintage, Ferrari-Carano wines exhibit remarkable consistency, style, and elegance, from delicate and seamless Sauvignon Blancs and Chardonnays to rich and complex Cabernet Sauvignons.
At Optivida our mission is to supply the safest and most effective products on the market. All our formulas are backed by extensive research and we guarantee your satisfaction. Stay tuned to learn more!
Ham is not just for holidays! While Thanksgiving is just around the corner, Kentucky Legend has a variety of products to fit any size of gathering.